Orchestra BioMed Holdings, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Orchestra BioMed Holdings, Inc. (OBIO) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-03-12
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-06-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2024-03-31 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-09-30 was $0.00.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2023-06-30 was -$102.00K.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2024 was $11.00K.
- Orchestra BioMed Holdings, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month as first filed | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | ||||
| 2024-12-31 | $11.00K 10-K · filed 2026-03-12 | ||||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-13 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | -$102.00K derived: sum of 2 quarters · filed 2024-11-12 | -$102.00K 10-Q · filed 2023-11-13 | -$102.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | -$102.00K 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2024-08-12 | -$102.00K 10-Q · filed 2023-08-10 | -$102.00K derived: sum of 3 quarters · filed 2024-05-13 | -$102.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | $0.00 derived: sum of 2 quarters · filed 2024-05-13 | $0.00 derived: sum of 3 quarters · filed 2024-05-13 | $0.00 derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $0.00 derived: sum of 2 quarters · filed 2024-03-27 | $0.00 derived: sum of 3 quarters · filed 2024-03-27 | $0.00 10-K · filed 2024-03-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 | $0.00 derived: sum of 2 quarters · filed 2023-11-13 | $0.00 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |